Skip to main content
. Author manuscript; available in PMC: 2012 Nov 29.
Published in final edited form as: Ann Oncol. 2009 Nov 4;21(1):98–103. doi: 10.1093/annonc/mdp496

Figure 3. Effect of 2mAbs treatment, versus gemcitabine, on the EGFR-expression, EGFR-phosphorylation, proliferation index-Ki67 and AKT-phosphorylation in BxPC-3 xenografts.

Figure 3

Tumor were resected 7 days after the beginning of therapy. Immunohistochemistry shows in: (A), EGFR expression (magnification × 10). (B), EGFR phosphorylation (magnification × 40). (C), Ki-67-index (magnification × 40). On the right: respective histograms in % positive cells. Western blot analysis shows in (D) the AKT-phosphorylation. GAPDH served as leading control. C+T: 2mAbs.